NASDAQ:MGNX

Macrogenics Stock Predictions

etoro logo Buy MGNX
*Your capital is at risk
$4.20
+0.150 (+3.70%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

MGNX Prediction Chart

MGNX Predictions History

Latest community submissions for MGNX.
Predictor Target Session Target Price Result Direction Accuracy Score
May 7, 2019 $17.69 -0.85% $17.84 X 99.15% 2
Jacob Jacob @Jacob.24742
Apr 30, 2018 $24.00 +4.08% $23.06 X 95.90% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MGNX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MACROGENICS
MacroGenics
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE